Benjamin E Low

Title: The Innovations of Benjamin E. Low

Introduction

Benjamin E. Low is a prominent inventor based in Bar Harbor, ME (US). He has made significant contributions to the field of biomedical research, particularly in the development of innovative mouse models for therapeutic applications. With a total of 2 patents, his work has advanced the understanding of various biological processes and therapeutic strategies.

Latest Patents

One of his latest patents is titled "Humanized mouse models of the FcRn recycling pathway." This patent provides improved humanized IgG1 FCRN mouse models that are essential for estimating the serum half-life of therapeutic proteins, such as monoclonal antibodies. Another notable patent is "Correction of Crb1 mutations," which involves genetically engineered mice that have a corrected Crb1 mutation. This invention includes methods for correcting the Crb1 mutation and provides kits, expression vectors, and fusion proteins for producing these genetically engineered mice.

Career Highlights

Benjamin E. Low is associated with The Jackson Laboratory, a leading research institution known for its contributions to genetics and genomics. His work at this institution has been pivotal in advancing research methodologies and therapeutic approaches in the biomedical field.

Collaborations

He has collaborated with notable colleagues, including Michael V. Wiles and Derry Roopenian, who have contributed to his research endeavors and innovations.

Conclusion

Benjamin E. Low's contributions to the field of biomedical research through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of therapeutic strategies and research methodologies.